我院2013-2014年萬古霉素臨床應(yīng)用分析
發(fā)布時(shí)間:2018-04-12 12:12
本文選題:萬古霉素 + 處方分析。 參考:《中國藥房》2015年20期
【摘要】:目的:為進(jìn)一步制定萬古霉素合理使用規(guī)范提供依據(jù)。方法:回顧性分析我院2013年6月-2014年12月經(jīng)靜脈使用萬古霉素的正常出院患者的相關(guān)信息。結(jié)果:178例使用萬古霉素的患者,平均年齡59.6歲,男性占73.60%,以肺部感染為主(74.72%)。用藥前輔助檢查充分,66.29%屬經(jīng)驗(yàn)性治療用藥,病原學(xué)送檢率達(dá)85.39%。71.91%的患者行治療藥物監(jiān)測(cè),但首次監(jiān)測(cè)血藥濃度僅47.66%處于目標(biāo)范圍。結(jié)論:萬古霉素在我院使用較為合理,但需關(guān)注經(jīng)驗(yàn)性用藥療程、治療藥物監(jiān)測(cè)的合理性以及個(gè)體化初始劑量等問題。
[Abstract]:Objective: to provide the basis for the establishment of reasonable use of vancomycin.Methods: the information of normal discharged patients receiving vancomycin from June 2013 to December 2014 was analyzed retrospectively.Results the average age of 178 patients with vancomycin was 59.6 years old. The male was 73.60 and the majority of them were pulmonary infection (74.72%).Before administration, 66.29% of the patients were treated with experiential therapy, 85.39% of the patients were examined by etiology, 71.91% of the patients were monitored for the treatment drugs, but only 47.66% of the patients were in the target range for the first time monitoring of blood drug concentration.Conclusion: the use of vancomycin in our hospital is reasonable, but attention should be paid to the experience course of medication, the rationality of drug monitoring and the individual initial dose.
【作者單位】: 廣州醫(yī)科大學(xué)附屬第一醫(yī)院藥學(xué)部;
【分類號(hào)】:R969.3
【參考文獻(xiàn)】
相關(guān)期刊論文 前1條
1 胡付品;朱德妹;汪復(fù);蔣曉飛;孫自鏞;陳中舉;胡志東;李金;謝軼;康梅;徐英春;張小江;張朝霞;季萍;王傳清;王愛敏;倪語星;孫景勇;俞云松;林潔;儲(chǔ)云卓;田素飛;徐元宏;沈繼錄;單斌;杜艷;卓超;蘇丹虹;張泓;孔菁;魏蓮花;吳玲;胡云建;艾效曼;;2013年中國CHINET細(xì)菌耐藥性監(jiān)測(cè)[J];中國感染與化療雜志;2014年05期
【共引文獻(xiàn)】
相關(guān)期刊論文 前10條
1 張偉霞;楊婉花;;臨床藥師在重癥監(jiān)護(hù)病房中開展藥學(xué)工作的體會(huì)[J];世界臨床藥物;2012年01期
2 徐紅冰;劉皋林;王曉平;;中樞神經(jīng)系統(tǒng)感染的藥物治療現(xiàn)狀[J];世界臨床藥物;2013年01期
3 常t,
本文編號(hào):1739701
本文鏈接:http://sikaile.net/yixuelunwen/yiyaoxuelunwen/1739701.html
最近更新
教材專著